Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 290

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Relative mortality from overdose of antidepressants

Open access
Henry, John A, Alexander, Carol A, Sener, Ersin K·1995·BMJ

Abstract

Objective : To compare the fatal toxicities of antidepressant drugs in 1987–92. Design : Retrospective epidemiological review of prescription data of the Department of Health, Scottish Office Home and Health Department, and Welsh Health Common Services Authority (excluding data from most private general practices and most hospitals), and mortality data from the Office of Population Censuses and Surveys and General Register Office in Scotland. Setting : General practice, England, Scotland, and Wales. Main outcome measures : Deaths per million prescriptions and deaths per defined daily dose. Results : 81.6% (1310/1606) of deaths from antidepressant overdose were due to two drugs, amitriptyline and dothiepin. The overall average of deaths per million prescriptions was 30.1. The overall rate for tricyclic drugs was 34.14 (95% confidence interval 32.47 to 38.86; P<0.001), monoamine oxidase inhibitors 13.48 (6.93 to 22.19; P<0.001), atypical drugs 6.19 (4.04 to 8.80; P<0.001), and selective serotonin reuptake inhibitors 2.02 (0.64 to 4.17; P<0.001). The numbers of deaths per million prescriptions of amoxapine, dothiepin, and amitriptyline were significantly higher than expected, while nine drugs had a significantly lower number of deaths per million prescriptions than expected. Analysis of deaths per defined daily dose showed a similar pattern. Conclusions : Safety in overdose should be considered in risk-benefit and cost-benefit considerations of antidepressants. A switch in prescribing, from drugs with a high number of deaths per million prescriptions to drugs with a low number, could reduce the numbers of deaths from overdose. Although this form of suicide prevention can be implemented easily and immediately, its introduction needs to be considered against the higher costs of some of the newer drugs. Key messages: Key messages Antidepressant drugs such as the selective serotonin reuptake inhibitors and lofepramine have low toxicity in overdose Deaths from overdose can be prevented by switching prescribing from older, tricyclic drugs; such a move may contribute to government targets for reducing suicide Choice of a first line antidepressant should be based on several factors, including adverse effect profile, compliance, overdose safety, and cost, and the antidepressant should be appropriate to the patient and his or her clinical condition Patients with evidence of suicidal ideation should be given special consideration—admission to hospital may be indicated

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.310.6974.221

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 290

Metadata

Authors
Henry, J. A., Alexander, C. A., & Sener, E. K.
Venue
BMJ
Publisher
BMJ
Published
1995-01-28
Volume
310
Issue
6974
Pages
221-224
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2131179717
Cited by
290
References
23
FWCI
35.07
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relative mortality from overdose of antidepressants. https://app.cochat.ai/papers/10.1136/bmj.310.6974.221
The paper
Henry, J. A., Alexander, C. A., & Sener, E. K. (1995). Relative mortality from overdose of antidepressants. BMJ. https://doi.org/10.1136/bmj.310.6974.221

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.